GlycoEra is positioned as the leading precision protein degradation company. Bifunctional biologics (G-LyTACs), designed by our novel and proprietary technology bind to disease-causing proteins and transport them to the lysosome using naturally occurring endocytic receptors. The disease-causing proteins are degraded in the lysosome and removed from the body.  Unlike intracellular protein degraders, like PROTACs and molecular glues, our technology can access targets that are extracellular and membrane proteins, thereby opening up novel targets and therapeutic areas for intervention.

Sofinnova Partners

5AM Ventures

LimmaTech Biologics

Roche Venture Fund

Bristol Myers Squibb

GlycoEra AG

We are thrilled to announce Santiago Arroyo, MD has joined our Board of Directors.  Dr. Arroyo brings a great deal of experience and clinical insights to help drive our science and platform to the next level.
#proteindegradation #science #degradation #experience

We kicked off the new year with a new home in Switzerland.  #proteindegradation #degradation

Are you attending BIO Partnering at JPM Week? Click below to send GlycoEra a meeting request in the BIO partnering system! #JPM2023 
 
https://lnkd.in/e2kAphtA

Are you attending JPM in San Francisco in January....we certainly are! Our team is looking forward to connecting with colleagues old and new. Reach out to Ganesh Kaundinya, Tanmoy Ganguly or Tanya Saggese if you want to get together. #jpm2023 #jpm23 #extracellular #circulating #JPMHC23 #proteindegradation

Schlieren, Switzerland - October 25, 2022 - GlycoEra will be presenting exciting data in Basel, Switzerland at the Festival of Biologics on November 3rd at 6 pm CET.  #biotechnology #proteindegradation #glycans

Newton, Mass. – October 20, 2022 – GlycoEra AG, a biotechnology company building a high-value pipeline of medicines based on deep expertise in protein degradation and glycobiology, today announced it will be presenting at the 5th Annual TPD Targeted Protein Degradation Conference, held October 25-28 at the DoubleTree by Hilton Hotel Boston North Shore, Danvers MA.  #biotechnology #tpd #proteindegradation #glycans

GlycoEra is a CustomGlycan platform that unlocks the power of glycan-mediated biology to develop a pipeline of novel biologics.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Feb 1, 2024 12:04 PM	ebf0da38
translate crunchbase fundingrounds	general
peers	general	Feb 1, 2024 12:04 PM	abc9d145
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:GLYCOERA

GlycoEra AG